File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.bbadis.2023.166695
- Scopus: eid_2-s2.0-85151447630
- WOS: WOS:001042055100001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin
Title | Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin |
---|---|
Authors | |
Keywords | Macrophage migration inhibitory factor (MIF) Melatonin NLR family pyrin domain containing 3 (NLRP3) Oral cancer Tumor associated macrophages (TAMs) |
Issue Date | 1-Jun-2023 |
Publisher | Elsevier |
Citation | BBA - Molecular Basis of Disease, 2023, v. 1869, n. 5 How to Cite? |
Abstract | Invasion and migration are significant challenges for treatment of oral squamous cell carcinomas (OSCCs). Tumor-associated macrophages (TAMs) interact with cancer cells and are involved in tumor progression. Our recent study demonstrated that melatonin inhibits OSCC invasion and migration; however, the mechanism by which melatonin influences crosstalk between TAMs and OSCCs is poorly understood. In this study, a co-culture system was established to explore the interactions between human monocytic cells (THP-1 cells) and human tongue squamous cell carcinoma cells (SCC-15 cells). The results were verified using monocyte-derived macro-phages (MDMs) isolated and differentiated from primary peripheral blood mononuclear cells. In vivo, assays were performed to confirm the anticancer effects of melatonin. SCC-15 cells co-cultured with THP-1 cells or MDMs exhibited increased migration and invasion, which was reversed by melatonin. Co-culture also increased the expression of macrophage migration inhibitory factor (MIF), CD40, CD163 and IL-1 & beta;, and these changes were also reversed by melatonin. Moreover, IL-1 & beta; secretion in THP-1 cells was MIF-and NLR family pyrin domain-containing 3 (NLRP3)-dependent, and treated with IL-1 & beta; enhanced the invasion and migration of SCC-15 cells. Furthermore, melatonin treatment significantly decreased tumor volumes and weights, and tumors from mice treated with melatonin had lower levels of MIF, NLRP3, and IL-1 & beta; than tumor from control mice. These results demonstrate that macrophages facilitate the progression of OSCCs by promoting the MIF/NLRP3/IL-1 & beta; signaling axis, which can be interrupted by melatonin. Therefore, melatonin could act as an alternative anti-cancer agent for OSCCs by targeting this signaling axis. |
Persistent Identifier | http://hdl.handle.net/10722/331513 |
ISSN | 2023 Impact Factor: 4.2 2023 SCImago Journal Rankings: 1.580 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, Leilei | - |
dc.contributor.author | Wang, Chuan | - |
dc.contributor.author | Tao, Zhuoying | - |
dc.contributor.author | Zhu, Wangyong | - |
dc.contributor.author | Su, Yuxiong | - |
dc.contributor.author | Choi, Wing Shan | - |
dc.date.accessioned | 2023-09-21T06:56:31Z | - |
dc.date.available | 2023-09-21T06:56:31Z | - |
dc.date.issued | 2023-06-01 | - |
dc.identifier.citation | BBA - Molecular Basis of Disease, 2023, v. 1869, n. 5 | - |
dc.identifier.issn | 0925-4439 | - |
dc.identifier.uri | http://hdl.handle.net/10722/331513 | - |
dc.description.abstract | <p>Invasion and migration are significant challenges for treatment of oral squamous cell carcinomas (OSCCs). Tumor-associated macrophages (TAMs) interact with cancer cells and are involved in tumor progression. Our recent study demonstrated that melatonin inhibits OSCC invasion and migration; however, the mechanism by which melatonin influences crosstalk between TAMs and OSCCs is poorly understood. In this study, a co-culture system was established to explore the interactions between human monocytic cells (THP-1 cells) and human tongue squamous cell carcinoma cells (SCC-15 cells). The results were verified using monocyte-derived macro-phages (MDMs) isolated and differentiated from primary peripheral blood mononuclear cells. In vivo, assays were performed to confirm the anticancer effects of melatonin. SCC-15 cells co-cultured with THP-1 cells or MDMs exhibited increased migration and invasion, which was reversed by melatonin. Co-culture also increased the expression of macrophage migration inhibitory factor (MIF), CD40, CD163 and IL-1 & beta;, and these changes were also reversed by melatonin. Moreover, IL-1 & beta; secretion in THP-1 cells was MIF-and NLR family pyrin domain-containing 3 (NLRP3)-dependent, and treated with IL-1 & beta; enhanced the invasion and migration of SCC-15 cells. Furthermore, melatonin treatment significantly decreased tumor volumes and weights, and tumors from mice treated with melatonin had lower levels of MIF, NLRP3, and IL-1 & beta; than tumor from control mice. These results demonstrate that macrophages facilitate the progression of OSCCs by promoting the MIF/NLRP3/IL-1 & beta; signaling axis, which can be interrupted by melatonin. Therefore, melatonin could act as an alternative anti-cancer agent for OSCCs by targeting this signaling axis.<br></p> | - |
dc.language | eng | - |
dc.publisher | Elsevier | - |
dc.relation.ispartof | BBA - Molecular Basis of Disease | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Macrophage migration inhibitory factor (MIF) | - |
dc.subject | Melatonin | - |
dc.subject | NLR family pyrin domain containing 3 (NLRP3) | - |
dc.subject | Oral cancer | - |
dc.subject | Tumor associated macrophages (TAMs) | - |
dc.title | Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bbadis.2023.166695 | - |
dc.identifier.scopus | eid_2-s2.0-85151447630 | - |
dc.identifier.volume | 1869 | - |
dc.identifier.issue | 5 | - |
dc.identifier.isi | WOS:001042055100001 | - |
dc.identifier.issnl | 0925-4439 | - |